Sue Drinkard
Nurse Practitioner · Greensboro, NCNPI 1053464966
Payments from drug & device makers
Across 106 payments — averaging $16.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$273
- Astellas Pharma US Inc$174
- Novartis$167
- AbbVie$121
- Boehringer Ingelheim$111
- Otsuka America Pharmaceutical, Inc.$109
- plus $746 from 24 others
What the payments were for
- Food & beverage$1,61895%
- Education$855%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 19 | $273 |
| Astellas Pharma US Inc | 8 | $174 |
| Novartis | 10 | $167 |
| AbbVie | 8 | $121 |
| Boehringer Ingelheim | 7 | $111 |
| Otsuka America Pharmaceutical, Inc. | 5 | $109 |
| GSK | 5 | $83 |
| Dexcom, Inc. | 5 | $78 |
| Merck | 6 | $78 |
| Novo Nordisk | 4 | $56 |
| Lifescan, Inc. | 3 | $46 |
| Abbott | 3 | $46 |
| Nestle Healthcare Nutrition Inc. | 3 | $40 |
| Cequr Corporation | 1 | $32 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| Amgen | 2 | $30 |
| AstraZeneca | 2 | $29 |
| Amneal Pharmaceuticals LLC | 1 | $23 |
| Seqirus USA Inc | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Irhythm Technologies, Inc. | 1 | $19 |
| Antares Pharma, Inc. | 1 | $17 |
| Madrigal Pharmaceuticals | 1 | $16 |
| Mannkind Corporation | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Johnson & Johnson | 1 | $13 |
| Xeris Pharmaceuticals, Inc. | 1 | $12 |
| Eisai Inc. | 1 | $11 |
| Amarin Pharma, Inc. | 1 | $11 |
| Sunovion Pharmaceuticals Inc. | 1 | $11 |
How this compares
$1,703 in reported general payments places this provider in the 80th percentile of 4,393 nurse practitioner providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lagevrio (Eua)Molnupiravir | 32 | $19,611 |
| Doxycycline Hyclate | 150 | $1,182 |
| Cefdinir | 62 | $809 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 34 | $551 |
| Omeprazole | 14 | $497 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 70 | $465 |
| Pantoprazole Sodium | 20 | $374 |
| Azithromycin | 106 | $326 |
| Prednisone | 210 | $320 |
| Fluticasone Propionate | 17 | $252 |
| Oseltamivir Phosphate | 13 | $239 |
| Warfarin Sodium | 12 | $209 |
| Triamcinolone Acetonide | 15 | $125 |
| Ondansetron Hcl | 11 | $86 |
| Amoxicillin | 20 | $54 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckLagevrio (Eua) | $78 | $19,61132 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,393 nurse practitioner providers in North Carolina.
Other nurse practitioner in Greensboro
- Amber SeilerGreensboro$55K
- Dawn DrazekGreensboro$18K
- Mary PrevostGreensboro$12K
- Sandrivette JohnsonRaleigh$573K
- Skyler RogersPinehurst$174K
- Jamie DinerDurham$170K
- Ayeshia WrightMocksville$145K
- Deborah AllenDurham$112K
- Jeanann VawterGastonia$97K
- Terra KampJacksonville$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.